[1]
L. Zhou and L. Peng, “Variations and Implications of Irisin, FGF-23, and N-MID Osteocalcin in Diabetic Osteoporosis Patients Undergoing Acarbose Plus Sitagliptin Therapy: A Prospective Cohort Analysis”, J Med Biochem, vol. 45, no. 3, pp. 529–538, Sep. 2025, doi: 10.5937/jomb0-60451.